Investor Presentation Full Year 2017

Investor Presentation Full year 2017 Slide 5 Executive management as of 15 February 2018 President & CEO Lars Fruergaard Jørgensen Research & Development Product Supply Commercial Strategy & Corporate Affairs North America Operations International Operations Biopharm & Legal Affairs Finance, Investor Relations & Procurement Business Services & Compliance Mads Krogsgaard Thomsen Henrik Wulff Camilla Sylvest Doug Langa¹ Maziar Mike Doustdar¹ Jesper Brandgaard Karsten Munk Lars Green Knudsen 1 Not registered with the Danish Business Authority novo nordisk

View entire presentation